By Alton Johnson, Ph.D., Principal, NGT Biopharma Consultants, and Katie Noah, R&D Project Manager, Catalent
Pharmaceutical and biotechnology companies approach external development and manufacturing partners for solutions for their product’s specific needs. New products are increasingly complex and must be developed in shorter timelines to meet patient needs. With the recent rise in accelerated designations (i.e., orphan drugs, fast track, etc.), advanced manufacturing technologies and smaller batch sizes are a growing trend. Read this executive summary for an in-depth look at flexible manufacturing including, the latest market drivers, approaches, and technology.